Upload File

 · gefitinib gefitinib 1. non-small cell lung cancer egfr dna egf-r exon 19 deletion, exon 21...

  • Home
  • Documents
  •  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
19

Upload: others

Post on 13-Feb-2020

5 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 2:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 3:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 4:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 5:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 6:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 7:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 8:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 9:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 10:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 11:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 12:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 13:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 14:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 15:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 16:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 17:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 18:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20
Page 19:  · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

cobas EGFR Mutation Test v2 · 2016-06-06 · cobas ® EGFR Mutation Test v2 07384351001-02EN Doc. Rev. 2.0 7 . mutations in exon 18, deletion mutations in exon 19, T790M and S768I

Lentivirus‑mediated silencing of CNTN1 enhances gefitinib

NSCLC overview - OverGroupEGFR-TKIs I line treatment of EGFR mutated NSCLC patients STUDIO TERAPIA PZ 0RR (%) PFS (m)IPASS Gefitinib vs CBDCA+Tax 261 71.2 vs 47.3 9.8 vs 6.4 First-Signal

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to … · exon 20 mutations were identified (Table 1). The most common mutation resulted in a duplication of codon 772

EXON - exeter.ox.ac.uk

Gefitinib Mylan, INN - Gefitinib · ASD - amorphous solid dispersion . AS - Active substance . ASM – Active Substance Manufacturer . ASMF - Active Substance Master File=DMF –

Routine-dose and High-dose Icotinib in Advanced Non-Small Cell … · 2020-02-14 · Non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 21 L858R

First-line afatinib vs gefitinib for patients with EGFR ... · ORIGINAL ARTICLE - CLINICAL ONCOLOGY First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC

GPR119 agonist enhances gefitinib responsiveness through

CARE™ Lung Cancer AACR 2020 Update - careeducation.ca › wp-content › uploads › 2020 › ... · CARE™ Lung Cancer AACR 2020 Update Target: EGFR Exon 20 Insertion Poziotinb

Dasatinib + Gefitinib, a non platinum-based combination

Biosensors and Bioelectronics - KAISTbel.kaist.ac.kr/extfiles/papers/20150827.pdf · Comprehensive detection of diverse exon 19 deletion mutations of EGFR in lung Cancer by a single

BMC Cancer - OnCommunity · During the 1 st EGFR-TKI treatment with gefitinib, 8 patients achieved PR as the best response (73%, Table 3), and 3 patients (27%) were SD. The median

What Should Physician Assistants Know about Genetics ... · 4/5/2001  · Cancer • familial • sporadic. ... Genomic Analysis. EGFr Mutation and Gefitinib Sensitivity in NSC Lung

DESIGN AND SYNTHESIS OF NEW EGFR - TYROSINE …applications.emro.who.int/imemrf/Bull_Pharm_Sci_Assiut_Univ/Bull... · Rania B. Bakr, et al. 28 O O O O Erlotinib I Gefitinib II N N

Therapeutic Advances in Medical Oncology › sites › default › files... · egfr egfr egfr egfr egfr nsclc. egfr egfr

IQWiG Reports – Commission No. A19-39 Dacomitinib (non ......(L858R) or exon 19 deletion (Del19) Research question 2: patients with other activating EGFR mutations The company followed

DETERMINATION OF SIMVASTATIN AND GEFITINIB IN BINARY

PMDA Perspectives on CDx · EGFR mutation detection kit approved in Japan RAPS2019 CDx gefitinib erlotinib afatinib osimertinib dacomitinib Therascreen EGFR mutation detection kit

PRODUCT MONOGRAPH NAT-Gefitinib

EGFR exon 20 insertion mutations and response to ... · mutations within the EGFR mutant lung cancer is incon-sistent, contributing to roughly 4–12% of all EGFR muta-tions identified

Molecular Cancer - RESEARCH Open Access Synergistic ......EGFR, including low molecular weight tyrosine kinase inhibitors [22]. Gefitinib (Iressa, ZD-1839) acts as a competitive inhibitor

Gefitinib Iressa Anticancer Medicine

Teràpies diana: fer un bon ús dels biomarcadors i del ...€¦ · Gefitinib EGFR mutation Erlotinib EGFR mutation Crizotinib Vemurafenib Imatinib Biomarker ... EGFR S492R (% of

PowerPoint Presentation · Retinoblastoma WT QRX-421 Exon 12 Exon 13 Exon 14 Exon 12 Exon 14 In-frame Exon 11 Exon 14 Out of-frame No AON QRX-421 Exon 12 Exon 13 Exon 14 Erwin van

Next Generation EGFR Inhibitors - Amazon S3 · The Chinese University of Hong Kong. EGFR TKIs First Generation-Gefitinib ... Osimertinib approved by FDA on Nov 13, ... Yang et al

Frequent EGFR mutations in nonsmall cell lung cancer ...tyrosine kinase inhibitor, gefitinib, lung cancer, miliary carcinomatosis L ung cancer is the leading cause of cancer-related

Efficacy of EGFR TKIs in Patients With NSCLC With Uncommon … · 2020. 7. 2. · 7 EGFR Exon 18Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib

EGFR exon 20 insertion mutations and response to osimertinib in … · 2019. 8. 15. · NSCLC cases. The most frequently identified EGFRexon20ins is A767_V769dup (17/53,32.1%). We

SUMMIT (PUMA-NER-5201) Basket Trial...5 SUMMIT study design for EGFR exon 18mutant lung cancer cohort EGFR exon 18-positive Lung Cancer Neratinib monotherapy (240 mg, oral daily) Clinical

Gefitinib Brands Medicine Online

CYP2D6 Variation v1 - PharmVarintron 1, exon 2, intron 2-exon 3, intron 4, exon 5, exon 7-intron 8, intron 7, exon 9 none Panserat et al. 1995 Gaedigk et al. 2010 Gaedigk et al, 2010

The challenge of targeting EGFR: experience with …...REVIEW The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer A.A. Armour and C.L. Watkins ABSTRACT:

INCLUSION COMPLEXATION OF GEFITINIB WITH …

exon 19 deletion (T751 I759>S) Gilotrif® (Afatinib) SAMPLE · 2020. 3. 26. · EGFR exon 19 deletion (T751_I759>S) CDx Associated Findings GENOMIC FINDINGS DETECTED FDFDAA-APPR-APPROOVED